Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

P62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay

ABSTRACT: p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay

PROVIDER: PRJNA389739 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay

Project description:p62/SQSTM1 was identified as a modulator of metastatic genes selectively enriched in melanoma in autophagy independent manner. iTRAQ quantitative proteomic approach was performed in melanoma cell lines (SK-Mel-103 and UACC-62) deficient for p62 to identify downstream effectors of p62. Similar studies were performed for ATG5, a core component of autophagy, as a reference for autophagy-associated changes in protein abundance. Additionally, melanoma cells were subjected to affinity purification (AP-MS) to identify the interactors of p62. Overall, these studies underscore a novel unexpected role of p62 regulating the stability of prometastatic factors via the interaction with RNA Binding Proteins, thus leading to the inhibition of protein translation.

2021-10-29 | PXD007000 | Pride

p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay [UACC62_6days]

Project description:Metastasis is a common cancer hallmark which however, may be acquired by tumor-type specific mechanisms. Here we identify p62/SQSTM1 as a modulator of metastatic genes selectively enriched in melanoma. Loss- and gain-of-function analyses of p62 effectors revealed FERMT2 as an indicator of poor patient prognosis. Analyses in tumor cells, clinical biopsies and genetically-engineered mice (to compare p62 vs. ATG5) demonstrated that known p62 roles in autophagy and stress responses were not essential in melanomas. Instead, a genome-wide transcriptomic/proteomic/interactomic approach demonstrated that p62 controls FERMT2 and yet additional pro-metastatic genes by modulating transcript stability. This function of p62 was exerted by recruiting RNA-binding proteins, here exemplified by IGF2BP1. These data illustrate how genetically altered cancers can coordinately fuel pro-metastatic signatures.

2018-07-05 | GSE99832 | GEO

p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay [UACC62_3days]

2018-07-05 | GSE99831 | GEO

p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay [SKMEL_6days]

2018-07-05 | GSE99830 | GEO

p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay [SKMEL_3days]

2018-07-05 | GSE99829 | GEO

Homo sapiens

Project description:p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay [SKMEL_6days]

| PRJNA389742 | ENA

Homo sapiens

Project description:p62 sustains a protumorigenic gene signature in melanoma opposing mRNA-dependent decay [SKMEL_3days]